Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling by Simon E. Koele, Thomas P. C. Dorlo, Caryn M. Upton, Rob E. Aarnoutse, Elin M. Svensson

Get full text

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic by Laurynas Mockeliunas, Rob C. van Wijk, Caryn M. Upton, Jonathan Peter, Andreas H. Diacon, Ulrika S. H. Simonsson

Get full text

Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling by Rob C. vanWijk, Laurynas Mockeliunas, Caryn M. Upton, Jonathan Peter, Andreas H. Diacon, Ulrika S. H. Simonsson

Get full text

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19 by Rob C. van Wijk, Laurynas Mockeliunas, Gerben van den Hoogen, Caryn M. Upton, Andreas H. Diacon, Ulrika S. H. Simonsson

Get full text

Transrenal Mycobacterium tuberculosis DNA in pulmonary tuberculosis patients during the first 14 days of treatment by Irina Kontsevaya, Jan Heyckendorf, Frauke Koops, Doris Hillemann, Torsten Goldmann, Caryn M. Upton, Veronique De Jager, Andreas Diacon, Christoph Lange

Get full text

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development by Laurynas Mockeliunas, Alan Faraj, Rob C. van Wijk, Caryn M. Upton, Gerben van den Hoogen, Andreas H. Diacon, Ulrika S. H. Simonsson

Get full text